ACACM Research, Inc. ACMR NASDAQ · Technology · United States
$39.80 -12.53% -$5.70
- Market cap
- $2.96B
- Enterprise value
- $2.42B
- P/E
- 25.5x
- Forward P/E
- 19.0x
- PEG
- -
- P/S
- 2.6x
- P/FCF
- -
- EV/EBITDA
- 11.0x
- ROIC
- 5.0%
- Gross margin
- 43.5%
- Net margin
- 10.2%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -2.4x
- Beta
- 2.23
- Free float
- 90.0%
About the company
ACM Research, Inc. is an American technology company specializing in the development, manufacturing, and sale of advanced wafer cleaning and coating equipment for the semiconductor industry. The company provides a wide range of innovative technologies and equipment for cleaning and coating semiconductor substrates, which are essential for the production of modern semiconductor components and microchips. ACM Research focuses on providing high-quality and efficient solutions that help increase performance, improve yields, and reduce costs in the semiconductor industry. With its innovative technology and global reach, ACM Research is recognized as a reliable partner for major players in the semiconductor industry. Investing in ACM Research, Inc. (ACMR) shares may be an interesting choice for investors who follow the technology sector and seek investment opportunities in a promising company operating in a rapidly evolving industry.
Sector
Technology
Industry
Semiconductors
CEO
David H. Wang
Employees
2,513
Headquarters
Fremont
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 32% a year over the last 3 years.
- What speaks for it: Analysts expect revenue to grow by 37% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: It reports a profit, yet spends more cash than it brings in.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $884.9M against $350.7M.
- What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number